R43IP001282
Project Grant
Overview
Grant Description
Low-cost and high efficiency DNA-based reverse genetics platforms for manufacturing RNA virus products.
Awardee
Funding Goals
NOT APPLICABLE
Grant Program (CFDA)
Awarding Agency
Funding Agency
Place of Performance
Philadelphia,
Pennsylvania
United States
Geographic Scope
City-Wide
Advanced Virology was awarded
Project Grant R43IP001282
worth $279,270
from the CDC Office of the Director in September 2025 with work to be completed primarily in Philadelphia Pennsylvania United States.
The grant
has a duration of 1 year and
was awarded through assistance program 93.283 Centers for Disease Control and Prevention Investigations and Technical Assistance.
The Project Grant was awarded through grant opportunity PHS 2023-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed).
Status
(Ongoing)
Last Modified 9/24/25
Period of Performance
9/30/25
Start Date
9/29/26
End Date
Funding Split
$279.3K
Federal Obligation
$0.0
Non-Federal Obligation
$279.3K
Total Obligated
Activity Timeline
Additional Detail
Award ID FAIN
R43IP001282
SAI Number
R43IP001282-232621461
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Small Business
Awarding Office
75CDC1 CDC Office of Financial Resources
Funding Office
75CA00 CDC OFFICE OF THE DIRECTOR
Awardee UEI
GDUKP33XANC6
Awardee CAGE
9EGW4
Performance District
PA-90
Senators
Robert Casey
John Fetterman
John Fetterman
Modified: 9/24/25